Companies /Healthcare

Pmv Pharmaceuticals Inc

NASDAQ: PMVP Biotechnology
$1.24
▼ $0.07 (−5.34%) today
Markets closed · 10:28pm ET
Today · % change

Fundamentals

Market Cap
$70.0M
EPS (TTM)
$-1.41
52-Week Range
$1 – $2
Street Target
$4.00

About PMV Pharmaceuticals

PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey.

PMVP Coverage